GUAFF
发表于 2025-3-21 18:02:13
书目名称Optimization of Pharmaceutical R&D Programs and Portfolios影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0703284<br><br> <br><br>书目名称Optimization of Pharmaceutical R&D Programs and Portfolios读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0703284<br><br> <br><br>
Hyperplasia
发表于 2025-3-21 22:35:20
http://reply.papertrans.cn/71/7033/703284/703284_2.png
cognizant
发表于 2025-3-22 04:23:22
http://reply.papertrans.cn/71/7033/703284/703284_3.png
anarchist
发表于 2025-3-22 05:27:18
Clinical Aspects of Pharmaceutical Portfolio Managementicially increase or decrease the estimated probability of registration or commercial success. Complex tools, such as including adaptive design principles, and large data software tools can also be utilized to minimize and mitigate the risk and bias embraced by both the R&D and commercial factors
令人心醉
发表于 2025-3-22 11:48:42
Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Developmhat these decisions are made at the portfolio level, as individual programs are interdependent. The value of a product depends on quality of product itself, and quality of development program. The value of a portfolio depends on the value of individual products and the strategy for portfolio optimization. Key concepts that are addressed here are:
付出
发表于 2025-3-22 13:03:20
Zoran AntonijevicAddresses the impact of study design on maximizing the output at the portfolio level in the pharmaceutical industry.Examines portfolio optimization comprehensively by integrating input from multiple s
不知疲倦
发表于 2025-3-22 18:20:09
978-3-319-34312-9Springer International Publishing Switzerland 2015
LATER
发表于 2025-3-23 00:52:05
http://reply.papertrans.cn/71/7033/703284/703284_8.png
坚毅
发表于 2025-3-23 04:51:52
Impact of Phase 2b Strategies on Optimization of Drug Development Programswill have a better chance to demonstrate a desirable risk/benefit profile and thus increase the chance of regulatory success and reimbursement by payors. It will also result in improved patient care and greater benefit to society. Multiple papers have been published within industry’s adaptive design working groups, and these are the key findings.
sclera
发表于 2025-3-23 07:32:07
http://reply.papertrans.cn/71/7033/703284/703284_10.png